Notice of Preliminary Results

About this update from Spire Healthcare Group Plc

Spire Healthcare Group plc   ('Spire Healthcare', 'the Company' or 'the Group')   Notice of Preliminary Results   29 January 2024   Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the UK, will announce its preliminary results for the year ended 31 December 2023 on Thursday, 29 February 2024.   A presentation for sell-side analysts and institutional investors will be held on the day of the preliminary results announcement at 9.00am GMT at the offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ. Refreshments will be available from 8.30am. If you wish to attend the presentation, please contact Instinctif Partners at [email protected] .   Following the presentation, there will be a moderated Q&A session.   For those who cannot attend in person, the presentation will also be accessible via live Zoom webcast.   Click the following link to register in advance for the Zoom webcast and to receive access details: https://spirehealthcare.zoom.us/webinar/register/WN_M9WnWjkDRzWqDVic-IA8VQ   A recording of the webcast will be made available from 1.00 pm on 29 February on the Spire Healthcare website, https://www.investors.spirehealthcare.com   - Ends - For further information please contact:   Spire Healthcare   Angus Prentice - Director of Investor Relations +44 (0)7974 982 512 Instinctif Partners   Damian Reece +44 (0)7931 598 593 Guy Scarborough +44 (0)7917 178 920   Registered Office and Head Office:   Spire Healthcare Group plc 3 Dorset Rise London EC4Y 8EN Registered number 09084066   About Spire Healthcare   Spire Healthcare is a leading independent healthcare group in the United Kingdom, with 39 hospitals and over 30 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 700 corporate clients.   Working in partnership with over 8,760 experienced consultants, Spire Healthcare delivered tailored, personalised care to approximately 926,500 inpatients, outpatients and day-case patients in 2022, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance (PMI) providers. 98% of Spire Healthcare's inspected hospitals and clinics are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Scotland and Wales.

View stock analysis, news, and events for Spire Healthcare Group Plc